KFS
AZN icon

Keynote Financial Services’s AstraZeneca AZN Stock Holding History

Keynote Financial Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Sell
1,134
-2
-0.2% -$386 0.12% 152
2025
Q4 		$209K Buy
+1,136
New +$199K 0.12% 154

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Keynote Financial Services's AZN Position: Q1 2026 in Review

Keynote Financial Services reduced its AstraZeneca (AZN) stake by 0.18% in Q1 2026, selling an estimated $386 and leaving 1,134 shares worth $224K. The position accounts for 0.12% of the portfolio, ranked #152.

Keynote Financial Services first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Keynote Financial Services held 1,134 shares of AstraZeneca worth $224K as of Q1 2026.
  • Keynote Financial Services sold 2 AstraZeneca shares in Q1 2026, an estimated $386.
  • AstraZeneca made up 0.12% of Keynote Financial Services's portfolio in Q1 2026, its #152 holding.
  • Keynote Financial Services first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.